Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Inner ear disorder
ADR ID BADD_A05933
ADR Hierarchy
04      Ear and labyrinth disorders
04.04      Inner ear and VIIIth cranial nerve disorders
04.04.02      Inner ear disorders NEC
04.04.02.002      Inner ear disorder
Description Not Available
MedDRA Code 10061524
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Disorder labyrinthine | Hyperactive labyrinth, bilateral | Hyperactive labyrinth, unilateral | Hypoactive labyrinth, bilateral | Hypoactive labyrinth, unilateral | Labyrinthine disorder | Labyrinthine disorder NOS | Labyrinthine disorders | Labyrinthine dysfunction | Labyrinthine dysfunction, unspecified | Loss of labyrinthine reactivity, bilateral | Loss of labyrinthine reactivity, unilateral | Other disorders of labyrinth | Other forms and combinations of labyrinthine dysfunction | Unspecified vertiginous syndromes and labyrinthine disorders | Labyrinthine dysfunction aggravated | Labyrinthine dysfunction aggrav. | Inner ear disorder NOS | Inner ear disorder
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01966Ropinirole--
BADD_D01974Rotigotine hydrochloride--
BADD_D01977Rufinamide--
BADD_D01989Saquinavir mesylate--
BADD_D01994Scopolamine--
BADD_D02007Semaxanib--
BADD_D02010Sertraline--
BADD_D02011Sertraline hydrochloride--
BADD_D02018Sildenafil--
BADD_D02029Sitagliptin--
BADD_D02031Sitaxentan--
BADD_D02058Sorafenib--
BADD_D02093Sulfasalazine--
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02106Tadalafil--
BADD_D02140Tegaserode--
BADD_D02143Telavancin--
BADD_D02146Telithromycin--
BADD_D02147Telmisartan--
BADD_D02150Temozolomide--
BADD_D02157Tenoxicam--
BADD_D02166Teriparatide--
BADD_D02170Testosterone--
BADD_D02192Thalidomide--
BADD_D02203Thiotepa--
BADD_D02214Ticagrelor--
BADD_D02221Tinidazole--
BADD_D02232Tobramycin--
BADD_D02236Tofacitinib0.001471%
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages